Development of a deep learning-based computational framework that predicts interactions for drug-drug or drug-food constituent pairs
A Korean research team from KAIST developed a computational framework, DeepDDI, that accurately predicts and generates 86 types of drug-drug and drug-food interactions as outputs of human-readable sentences, which allows in-depth understanding of the drug-drug and drug-food interactions.
Drug interactions, including drug-drug interactions (DDIs) and drug-food constituent interactions (DFIs), can trigger unexpected pharmacological effects, including adverse drug events (ADEs), with causal mechanisms often unknown. However, current prediction methods do not provide sufficient details beyond the chance of DDI occurrence, or require detailed drug information often unavailable for DDI prediction.
To tackle this problem, Dr. Jae Yong Ryu, Assistant Professor Hyun Uk Kim and Distinguished Professor Sang Yup Lee, all from the Department of Chemical and Biomolecular Engineering at Korea Advanced Institute of Science and Technology (KAIST), developed a computational framework, named DeepDDI, that accurately predicts 86 DDI types for a given drug pair. The research results were published online in Proceedings of the National Academy of Sciences of the United States of America (PNAS) on April 16, 2018, which is entitled “Deep learning improves prediction of drug-drug and drug-food interactions.”
DeepDDI takes structural information and names of two drugs in pair as inputs, and predicts relevant DDI types for the input drug pair. DeepDDI uses deep neural network to predict 86 DDI types with a mean accuracy of 92.4% using the DrugBank gold standard DDI dataset covering 192,284 DDIs contributed by 191,878 drug pairs. Very importantly, DDI types predicted by DeepDDI are generated in the form of human-readable sentences as outputs, which describe changes in pharmacological effects and/or the risk of ADEs as a result of the interaction between two drugs in pair. For example, DeepDDI output sentences describing potential interactions between oxycodone (opioid pain medication) and atazanavir (antiretroviral medication) were generated as follows: “The metabolism of Oxycodone can be decreased when combined with Atazanavir”; and “The risk or severity of adverse effects can be increased when Oxycodone is combined with Atazanavir”. By doing this, DeepDDI can provide more specific information on drug interactions beyond the occurrence chance of DDIs or ADEs typically reported to date.
DeepDDI was first used to predict DDI types of 2,329,561 drug pairs from all possible combinations of 2,159 approved drugs, from which DDI types of 487,632 drug pairs were newly predicted. Also, DeepDDI can be used to suggest which drug or food to avoid during medication in order to minimize the chance of adverse drug events or optimize the drug efficacy. To this end, DeepDDI was used to suggest potential causal mechanisms for the reported ADEs of 9,284 drug pairs, and also predict alternative drug candidates for 62,707 drug pairs having negative health effects to keep only the beneficial effects. Furthermore, DeepDDI was applied to 3,288,157 drug-food constituent pairs (2,159 approved drugs and 1,523 well-characterized food constituents) to predict DFIs. The effects of 256 food constituents on pharmacological effects of interacting drugs and bioactivities of 149 food constituents were also finally predicted. All these prediction results can be useful if an individual is taking medications for a specific (chronic) disease such as hypertension or diabetes mellitus type 2.
Distinguished Professor Sang Yup Lee said, “We have developed a platform technology DeepDDI that will allow precision medicine in the era of Fourth Industrial Revolution. DeepDDI can serve to provide important information on drug prescription and dietary suggestions while taking certain drugs to maximize health benefits and ultimately help maintain a healthy life in this aging society.”
The Latest on: Drug-drug or drug-food interactions
via Google News
The Latest on: Drug-drug or drug-food interactions
- How to Take Alpelisib and Dose of Alpelisibon March 2, 2021 at 5:32 am
Dose of Alpelisib should be taken with food and at the same time every day. The tablets of Alpelisib should be swallowed whole. Do not crush, chew or spilt the tablet. Do not take the tablet if it ...
- Critical Care Pharmacy Services in United States Hospitalson February 26, 2021 at 4:01 pm
Creates and maintains inpatient drug profiles (F) 99.1 Alerts users to drug allergies (F) 97.5 Alerts users to drug-drug interactions ... 71.1 Alerts users to drug-food/nutrient interactions ...
- This Innovative Blockchain-Based Digital Therapeutics Will Increase Efficacy Of Pillson February 22, 2021 at 1:54 am
Epillo’s ‘INTRx’ offering uses their proprietary medical AI to combat millions of unsupervised and neglected drug-food and drug-drug interactions in-home and clinical settings. Epillo’s ...
- Developing and Implementing a Pharmacist-Managed, Telephone-Based Helicobacter pylori Clinicon January 16, 2021 at 4:00 pm
Because we focused on drug interactions and medication safety, no significant drug-drug or drug-food interactions were recorded. Although not formally evaluated, patient satisfaction with this ...
- PA Program Overviewon August 16, 2020 at 8:50 pm
The curriculum is structured around active-learning strategies, practical lab sessions, simulated case presentations, problem-based learning sessions, and off-campus clinical interaction. The Clinical ...
- Check for Drug Interactionson March 19, 2020 at 11:30 pm
Most commonly there are three types of drug interactions: Drug-drug interaction ... This can be dangerous when you are driving a car. Drug-food interaction:The drug reacts with food or beverage.
- Is tecarfarin a better anticoagulant than warfarin?on May 21, 2019 at 6:27 am
By contrast, warfarin is metabolized by multiple enzymes in the CYP450 system, making it susceptible to drug–drug and drug–food interactions, and meaning that it produces highly variable ...
- Anticoagulation Managementon May 7, 2016 at 2:37 pm
The manual details dosing and monitoring suggestions (including drug-drug and drug-food interactions) for managing patients treated with heparin, low molecular weight heparins, factor Xa inhibitors, ...
- Drug Interaction Checkeron January 11, 2014 at 1:11 am
The information provided here is for informational purposes only. This tool may not cover all possible drug interactions. Please check with a physician if you have health questions or concerns.
via Bing News